PARP1 and neoplasm: Sublethal alkannin-induced DNA damage sensitized colorectal cancer cells to the PARP inhibitor olaparib, and coadministration of alkannin and olaparib resulted in synergistic lethality in colorectal cancer cells and effectively suppressed the growth of tumor xenografts in vivo.